Home > Clinical Trials
Check All Search

Saved trials

Completed
NCT01463150
Prasugrel 5mg Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Aged ≥75 Years and/or Weighing <60 kg Post Percutaneous Coronary Intervention (PCI)
27 Enrollment(s)
1 Study location(s)
Interventional (Phase IV)
Platelet Reactivity
Completed
NCT01175200
Double the Dose of Clopidogrel or Switch to Prasugrel to Antagonize Proton Pump Inhibitor Interaction.
82 Enrollment(s)
1 Study location(s)
Interventional (Not Applicable)
Anti Platelet Effects
Completed
NCT01360437
Ticagrelor Versus Prasugrel in Acute Coronary Syndromes After Percutaneous Coronary Intervention
44 Enrollment(s)
1 Study location(s)
Interventional (Phase III)
Coronary Artery Disease
Acute Coronary Syndrome
Completed
NCT01102491
Additional Anti-emetic Effect of Ramosetron Prophylaxis After Total Knee Arthroplasty
153 Enrollment(s)
1 Study location(s)
Interventional (Phase IV)
Osteoarthritis, Knee
Terminated
NCT00910299
Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel (TRIGGER-PCI)
423 Enrollment(s)
27 Study location(s)
Interventional (Phase II)
Coronary Artery Disease (CAD)
Terminated
NCT00995514
Genotype Guided Comparison of Clopidogrel and Prasugrel Outcomes Study
4,471 Enrollment(s)
1 Study location(s)
Observational
Cardiovascular Disease
Completed
NCT01505790
Impact of Clopidogrel Dose Adjustment According to Platelet Reactivity Monitoring in Patients With High on Treatment Platelet Reactivity Undergoing Percutaneous Coronary Intervention
187 Enrollment(s)
1 Study location(s)
Interventional (Phase III)
Acute Coronary Syndromes
Unknown status
NCT01598337
The Effect Of Antiplatelets Therapy On Saphenous Vein Coronary Artery Bypass Graft Patency
200 Enrollment(s)
1 Study location(s)
Interventional (Phase III)
Coronary Artery Disease